Table 2.
Exosomes | Microvesicles | Apoptotic Bodies | |
---|---|---|---|
Size | 30–100 nm | 100–1000 nm | 1–5 µm |
Density | 1.13–1.19 g/mL | 1.25–1.30 g/mL | 1.16–1.28 g/mL |
Origin and release mechanisms | Inward budding of endosomes to create multivesicular bodies, which fuse with the plasma membrane and release containing vesicles. | Direct outward budding (blebbing) of the plasma membrane, accompanied by cytoskeleton rearrangements and phospholipids’ relocation to the outer membrane. | Blebbing of plasma membrane during cell death, cellular debris. |
Lipid membrane composition | Similar to donor cells’ plasma membrane (includes bone morphogenetic protein): lysobisphosphatidic acid, cholesterol, ceramide, sphingomyelin, phosphatidylcholine, phosphatidyl-ethanolamine, ganglioside GM3, phosphatidylinositol. | Characterized by high phosphatidylserine externalization. High levels of cholesterol, sphingomyelin, and ceramide. |
Similar to parental cells’ plasma membrane (without bone morphogenetic protein): cholesterol, phosphatidylserine. |
Markers | Membrane impermeable (PI negative). Alix, TSG101, CD9, CD63, CD81, CD82, CD89, flotillin, annexin, hsp70, hsp90. |
Membrane impermeable (PI negative). Integrins, selectins, flotilin-2, other antigens of parental cell, phosphatidylserine. |
Membrane permeable (PI positive). Histones, DNA, phosphatidylserine. |
Cargo | DNA, mRNA, miRNA, lipids, specific proteins | DNA, mRNA, miRNA, lipids, specific proteins | Cellular organelles, RNA, fragmented DNA, proteins |
References | [19,21,110,111,112,113,114,115,116,117] | [21,112,116,118] | [21,110,113,114,116] |
ALIX, apoptosis-linked gene 2-interacting protein X; hsp70, 70 kilodalton heat shock protein; hsp90, 90 kilodalton heat shock protein; mRNA, messenger RNA; miRNA, microRNA; PI, Propidium iodide; TSG101, tumor susceptibility gene 101.